News & Events

News 2019-08-12T17:37:54+00:00

Apr
22

PORTFOLIO NEWS: Tanner Pharma Group Expands US Operations with New Facility in Charlotte, NC

April 22, 2025

Apr
11

Bourne Partners Grows its Sponsor Coverage Team with the Addition of Will Breeyear

April 11, 2025

Mar
26

Bourne Leadership: Investment Outlook McGuire Woods Podcast With Jeremy Johnson

March 26, 2025

Mar
12

Bourne Partners Welcomes John Chiminski as Senior Advisor

March 12, 2025

Mar
11

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

March 11, 2025

Feb
24

BPSC PORTFOLIO COMPANY NEWS: Enhanced Healthcare Partners and Bourne Partners Strategic Capital Sells PAI Pharma

February 24, 2025

Feb
21

bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital

February 21, 2025

Jan
14

BPSC PORTFOLIO COMPANY NEWS: American Injectables Receives FDA Approval

January 14, 2025

Oct
14

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing

October 14, 2024

Sep
12

Bourne Partners Advises Nivagen Pharmaceuticals on the Sale of Its MedisourceRx Business Unit to a Leading Health and Wellness Company

September 12, 2024

Aug
19

Bourne Partners Continues to Grow its Investment Banking Team with the Addition of Evan Goldstein, Vice President, Healthcare Services

August 19, 2024

Aug
6

Bourne Partners Continues to Grow its Investment Banking Team with the Addition of Ryan Silvester as Vice President, PharmaTech & Healthcare Technology

August 6, 2024

May
28

Don Hooker Joins Bourne Partners as Director and Head of Research, Enhancing Healthcare Coverage and Bolstering Research Capabilities

May 28, 2024

May
20

Bourne Partners Expands, Launching Healthcare Services Coverage with Addition of Aaron Olson as Managing Director, Head of Healthcare Services

May 20, 2024

May
1

Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health

May 1, 2024

Apr
3

Reverba Completes Acquisition of Six Degrees Worldwide to Unite Science and the Patient Voice to Advance Healthcare

April 3, 2024

Mar
25

Matthew Bullard Joins Bourne Partners as a Strategic Advisor

March 25, 2024

Feb
1

Greenphire Announces Acquisition of Clincierge to Enhance Clinical Trial Support Services

February 1, 2024

Jan
30

Arlington Capital Partners Announces Majority Investment in Afton Scientific

January 30, 2024

Jan
18

Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development and Manufacturing Organization

January 18, 2024

Jun
6

Capital IP and Ghost Tree Provide $40MM to Israel-based Women Health focused ConTIPI Medical

June 6, 2023

May
24

Indegene expands partnership with ConTIPI Medical Ltd to manage pelvic organ prolapse in women worldwide

May 24, 2023

May
11

UpHealth Announces Closing of Sale of Innovations Group Incorporated to Belmar Pharma Solutions for $56.0 Million in Gross Proceeds

May 11, 2023

Feb
27

UpHealth Announces Strategic Sale of Innovations Group Incorporated to Belmar Pharma Solutions for Approximately $56 Million in Gross Proceeds

February 27, 2023

Aug
22

LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc.

August 22, 2022

Aug
1

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

August 1, 2022

Mar
24

PORTFOLIO NEWS: Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine

March 24, 2022

Mar
7

Martin Zentgraf Joins Bourne Partners as a Senior Advisor

March 7, 2022

Feb
2

Bourne Partners Advises Fagron on Divestment of Non-Core CDMO Business

February 2, 2022

Feb
1

Hildred Capital Management, LLC, Bourne Partners Strategic Capital and The Emerson Group Launch Carlin Consumer Health

February 1, 2022

Dec
15

Alcami Announces the Acquisition of Masy BioServices

December 15, 2021

Nov
22

ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses

November 22, 2021

Oct
4

Bourne Partners and Bourne Partners Strategic Capital (“BPSC”) Celebrate 20 Years of Adding Value Beyond the Deal™

October 4, 2021

Aug
18

Bourne Partners Advises Woodward Pharma on Branded Pharmaceuticals Acquisitions and $125 Million Financing

August 18, 2021

Aug
5

PORTFOLIO NEWS: Tanner Pharma Group Gives Donation to Benefit MAP International’s Bringing Children Health Program

August 5, 2021

May
21

Bourne Partners Advises Nuvera on its Acquisition by Ashfield Engage

May 21, 2021

May
6

Paul Campanelli Joins Bourne Partners as a Senior Advisor

May 6, 2021

Mar
9

Bourne Partners Advises ANI Pharmaceuticals on Acquisition of Novitium Pharma

March 9, 2021

Mar
3

Indegene and ConTIPI Medical Ltd partner to bring innovative disposable non-surgical device to market to help women suffering from Pelvic Organ Prolapse (POP)

March 3, 2021

Feb
25

PORTFOLIO NEWS: Pharmaceutical Associates, Inc. Names Industry Leader Domenic Ciarico as Chief Commercial Officer

February 25, 2021

Dec
2

Bourne Partners Advises Apollo Pharmaceuticals USA on Sale to Provepharm Life Solutions

December 2, 2020

Oct
29

Bourne Partners Strategic Capital and Meeting Street Capital Jointly Back PBM Veteran Artemis Emslie in Cadence Rx

October 29, 2020

Sep
24

American Injectables Inc. Secures $10 Million in Series A Financing to Expand Portfolio at US-Based Manufacturing Facility

September 24, 2020

Jul
27

PORTFOLIO NEWS: Elevar Therapeutics and Tanner Pharma Group Announce Global Named Patient Program to Provide Access to Apealea® (micellular paclitaxel)

July 27, 2020

May
26

Millicent Pharma Acquires the U.S. Commercial Rights to Intrarosa® from AMAG Pharmaceuticals

May 26, 2020

Apr
6

Pharmaceutical Associates Inc. Announces the Appointment of Healthcare Veteran Paul Campanelli as New Board Member

April 6, 2020

Mar
25

PORTFOLIO NEWS: Tanner Pharma Group announces Leukine Emergency Access Program (LEAP) to provide increased international access to Leukine® (Sargramostim)

March 25, 2020

Mar
5

Bourne Partners and The Emerson Group Form Daybreak Consumer Care to Build Global Consumer Healthcare Company

March 5, 2020

Mar
3

PORTFOLIO NEWS: Tanner Pharma Group Initiates Named Patient Programs for XIAFLEX

March 3, 2020

Feb
13

PORTFOLIO NEWS: Funds Managed by Affiliates of Apollo Global Management to Acquire Covis Pharma From Cerberus

February 13, 2020

Nov
6

Bourne Partners Strategic Capital Announces Investment in Pharmaceutical Associates, Inc.

November 6, 2019

Jan
23

PORTFOLIO NEWS: PQMD Welcomes Tanner Pharma Group to Membership

January 23, 2019

Jan
2

Cambrex Completes Acquisition of Avista Pharma Solutions

January 2, 2019

Dec
17

Bourne Partners Facilitates Sale of Endo’s Alabama Manufacturing Facility to Consortium of Buyers

December 17, 2018

Dec
17

PORTFOLIO NEWS: Capital One Closes $350MM Senior Credit Facility for Covis Pharma

December 17, 2018

Nov
20

Bourne Partners Advises Avista Pharma Solutions on Sale to Cambrex Corp. for $252 Million

November 20, 2018

Nov
7

PORTFOLIO NEWS: Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma

November 7, 2018

Aug
7

PORTFOLIO NEWS: Tanner Pharma Group Signs Distribution Agreement with Nephcentric LLC

August 7, 2018

Jul
30

PORTFOLIO NEWS: Tanner Pharma Group Signs Distribution Agreement with MannKind Corporation

July 30, 2018

Jun
29

Bourne Advises Endo on Sale of Portfolio of Oral Solid ANDAs

June 29, 2018

Jun
6

PORTFOLIO NEWS: Tanner Pharma Group Delivers on “Last Mile” in Global Health

June 6, 2018

May
24

PORTFOLIO NEWS: Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics’ Product, Leukine®

May 24, 2018

May
21

Bourne Partners, The Carlyle Group and Industry Veterans Launch Millicent Pharma with Femring Acquisition

May 21, 2018

May
7

Bourne Advises Endo on Sale of Several ANDAs to Lannett

May 7, 2018

Apr
17

Bourne Partners Advises Accelovance on Sale to Linical

April 17, 2018

Oct
2

Bourne Partners to Host 7th Annual Global Healthcare Executive Summit

October 2, 2017

Sep
6

Bourne Partners Advises Accelovance on Sale of SMO, Optimal Research

September 6, 2017

Aug
31

Bourne Partners Advises The Carlyle Group on Acquisition of AMRI

August 31, 2017

Mar
29

Bourne Partners Advises Prophase Labs, Inc. on $50 million Sale of Cold-EEZE® Brand to Mylan N.V.

March 29, 2017

Jan
9

Bourne Partners Advises Prophase Labs, Inc. On Agreement To Sell Cold-EEZE(R) Brand

January 9, 2017

Oct
20

Bourne Partners to Host Sixth Annual Global Healthcare Executive Summit

October 20, 2016

Jan
5

The Carlyle Group and Bourne Partners Form Phoenix Therapeutics to Build Global Pharma Company

January 5, 2016

Nov
16

Banks Bourne Delivers Keynote at SEBIO

November 16, 2015

Oct
21

Bourne Partners Advises Cinven on $3.5 billion Sale of AMCo to Concordia Healthcare Corporation

October 21, 2015

Oct
6

Bourne Partners Represents Concordia Healthcare Corp. in Its Sale of Three Injectable Products to IGI Laboratories

October 6, 2015

Sep
8

Executives From Leading Pharmaceutical and Biotech Companies Discuss Industry Trends at Annual Bourne Partners Summit

September 8, 2015

Jul
30

Bourne Partners to Host Fifth Annual Global Healthcare Executive Summit

July 30, 2015

Apr
21

Bourne Partners Advises Portfolio Company, Covis Pharma Sàrl, on Deal to Sell Some Assets to Concordia for $1.2 Billion

April 21, 2015